Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

NYU Langone Health

Status: Enrolling

Conditions: Prostate Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT07184957

17-00354

Details and patient eligibility

About

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Enrollment: 1,000 estimated patients

Sex: Male

Ages: 40 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
• Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

Exclusion criteria

• Men that are not diagnosed with prostate cancer.
• Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Trial design

1,000 participants in 1 patient group

Men with Prostate Cancer

Description:

Men who receive cryotherapy for ablation of clinically localized prostate cancer.